Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intranasal Freeze-dried Live Attenuated Influenza Vaccine in Chinese Subjects
NCT02665871Phase 1Unknown
- Sponsor
- Beijing Chaoyang District Center for Disease Control and Prevention
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 1, randomised trial of live attenuated influenza vaccine in influenza (4 arms), sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Primary endpoint: Rate of adverse reactions at 3 months. Status: unknown.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02665871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665871.